Connect with us
Grifols explained that the Strategic Alliance and Share Purchase Agreement signed with Haier on December 29th, 2023, is “binding” and that both parties are contractually obliged...
Qube Research & Technologies increases its short position on Grifols to 1.23%, up from 1.19%, amid market volatility due to the conflict with Gotham City Research....
BlackRock increased its stake in Grifols to 4.2% amid the Spanish company's legal dispute with Gotham City Research. The 4.1% rise in Grifols' stock boosted the...
The presentation of the results was scheduled for the end of February, but Grifols wants to move forward so that the situation is not unsustainable for...
The intraday minimum was marked at 10:31 a.m., with 8.22 euros, after the stock spent an hour and a half in a volatility auction trying to...
Grifols is a listed Catalan pharmaceutical company. The company's activity focuses on the research, development, manufacturing, and marketing of products derived from plasma (blood products), intravenous therapy...
Reig Jofre is the only one that does not follow the upward trend of the Spanish pharmaceutical sector and closes the third quarter with a decrease...
In recent years, Grifols has invested in its innovation infrastructure and currently has more than 1,200 people who work together in four global research centers. In 2021,...
Grifols is a publicly traded Catalan pharmaceutical company. The company's activity is focused on the research, development, manufacturing, and marketing of plasma-derived products (blood products), intravenous...
Grifols has lost around 70% of its market value since the start of the pandemic. In the eyes of investors, its main burdens are debt, which...